Background:
@EN Persistent facial telangiectasia, erythema, and flushing are the major cosmetic problems in patients with rosacea. However various therapeutic modalities for rosacea papules and pustules, including topical antibiotics, systemic antibiotics,
isotretinoin, and systemic and topical metronidazole, are not effective in reducing telangiectasia and flushing reactions present in rosacea patients.
The flashlamp-pumped pulsed dye laser has been described as a successful treatment for port wine stains with telangiectasia as part of their abnomalities. A clinical study was therefore undertaken in a group of rosacea patients, who recieves this
laser
to areas of facial cutaneous lesion.
@ES Objective:
@EN The purpose of the study was to evaluate the therapeutic effect of the flashlamp-pumped pulsed dye laser(SPTL-1) for rosacea, especially telangiectasia and flushing reactions.
@ES Objective:
@EN The purpose of the was to evaluate the therapeutic effect of the flashlamp-pumped pulsed dye laser(SPTL-1) for rosacea, especially telangiectasia and flushing reactions.
@ES Methods:
@EN Forty-eight patients with rosacea were studied to evaluate the therapeutic effects of the SPTL-1 flashlamp-pumed pulsed dye laser (Candela corp., Wayland, Mass.) at the Department of Dermatology in Dong-A University Hospital for 20 months
from
January 1991 to August 1992.
@ES Results:
@EN 1. Total therapeutic effects of this SPTL-1 laser showed excellent results in 22.9%, good in 62.5%, fair in 8.3%, and poor in 6.3%.
2. Therapeutic effects of rosacea-associated lesions showed excellent or good results in 85.4% of patients with erythema and telangiectasia, 84% patients with papules, 100% patients with pustules, and 93.7% of patients with facial flushing.
3. Complications included transient hyperpigmentation(14.6%), secondary bacterial infection(6.3%), hypopigmentation(2.1%), and tropic scar(2.1%).
4. The recurrence rate were 2.9%.
@ES Conclusion:
@EN The flashlamp-pumped pulsed dye laser (SPTL-1) is a very effective mode of treatment for rosacea, including persistent telangiectasia and facial flushing rections which were intractable to previous other therapeutic modalities. (Kor J
Dermatol
1994
; 32(4) : 649~654)
|